Enhancing Bioanalysis and Drug Development with Advanced Tools and Technologies.

The article focuses on the advancements in bioanalysis driven by artificial intelligence (AI), machine learning (ML), and innovative instrumentation, which are enhancing drug development processes. It discusses how AI and ML are increasingly integrated into bioanalytical methods to improve data eval...

Descripción completa

Detalles Bibliográficos
Publicado en:Pharmaceutical Technology Vol. 49; no. 8; pp. 10 - 13
Autor principal: Haigney, Susan
Formato: questions and answers Journal Article
Publicado: MJH Life Sciences Oct2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188633420&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 188633420
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15432521
        4FK
      jtl: Pharmaceutical Technology
      issn: 15432521
      maglogo: N
    pubinfo:
      dt: Oct2025
      vid: 49
      iid: 8
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        188633420
        188633420
        188633420
        188633420
      ppf: 10
      ppct: 3
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Enhancing Bioanalysis and Drug Development with Advanced Tools and Technologies.
      aug:
        au: Haigney, Susan
      sug:
        subj:
          Drug Development Methods
          Artificial Intelligence Utilization
          Biological Assay
          Technology, Medical
          Bioinformatics
          Pharmacokinetics
          Biological Markers
          Quality Assurance
          Clinical Laboratory Information Systems
      ab: The article focuses on the advancements in bioanalysis driven by artificial intelligence (AI), machine learning (ML), and innovative instrumentation, which are enhancing drug development processes. It discusses how AI and ML are increasingly integrated into bioanalytical methods to improve data evaluation, automate processes, and ensure regulatory compliance, while also addressing challenges such as sensitivity and sample size. The article highlights the role of large language models (LLMs) in streamlining documentation and improving workflows, as well as the importance of high-resolution mass spectrometry (HRMS) and other advanced technologies in achieving precise quantification of complex molecules. Additionally, it notes the impact of evolving regulations on bioanalytical practices, emphasizing the need for compliance and adaptation to new standards in the pharmaceutical industry.
      pubtype: Trade Publication
      doctype:
        questions and answers
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N